Crohn’s and Parkinson disease: is LRRK2 lurking around the corner?
- 17 April 2018
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Gastroenterology & Hepatology
- Vol. 15 (6) , 330-331
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s diseaseScience Translational Medicine, 2018
- Occurrence of Crohn's disease with Parkinson’s diseaseParkinsonism & Related Disorders, 2017
- Association Between Parkinsonʼs Disease and Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2016
- Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populationsNature Genetics, 2015
- LRRK2 Inhibition Attenuates Microglial Inflammatory ResponsesThe Journal of Neuroscience, 2012
- Parkinson diseaseNeurology, 2011
- The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel diseaseNature Immunology, 2011
- CARD15 variants in patients with sporadic Parkinson's diseaseNeuroscience Research, 2007